Categories: News

Doximity to Participate in Upcoming Investor Events

SAN FRANCISCO, Feb. 10, 2022 /PRNewswire/ — Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that it will participate in virtual fireside chats at the following upcoming investor events.

SVB Leerink Virtual 11th Annual Global Healthcare Conference

Date: February 16, 2022
Presentation Time: 1:40 pm ET/10:40 am PT
Speaker: Anna Bryson, Chief Financial Officer

Morgan Stanley Technology, Media & Telecom Conference 2022

Date: March 10, 2022
Presentation Time: 4:50 pm ET/1:50 pm PT
Speaker: Jeff Tangney, co-founder and Chief Executive Officer

Both presentations will be webcast. Links to the live and archived webcasts will be available on Doximity’s investor relations website at https://investors.doximity.com/.

About Doximity
Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company’s network members include over 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and conduct virtual patient visits. Doximity’s mission is to help doctors be more productive so they can provide better care for their patients.

For investors:
Perry Gold
ir@doximity.com

For media:
pr@doximity.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/doximity-to-participate-in-upcoming-investor-events-301480144.html

SOURCE Doximity, Inc.

Staff

Recent Posts

Global Microscopy Market to Reach USD 10.6 Billion by 2029 driven by Healthcare Innovations | MarketsandMarkets™

CHICAGO, July 4, 2024 /PRNewswire/ -- The global microscopy market is poised for significant growth, expected…

4 hours ago

FSD Pharma Files Amended and Restated Material Change Report

Toronto, Ontario--(Newsfile Corp. - July 4, 2024) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE)…

7 hours ago

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) -- Global biotechnology leader CSL Behring (ASX: CSL)…

7 hours ago

ICPO Foundation partners with Nuclear Medicine Research Infrastructure (NuMeRI) to establish an ICPO Collaborating Center

ICPO Center NuMeRI ICPO Foundation signed the contract with Nuclear Medicine Research Infrastructure (NuMeRI) to…

7 hours ago

Psyence Biomedical Ltd. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM)…

7 hours ago